Hana Pharm Co Ltd
KRX:293480
Hana Pharm Co Ltd
Gross Profit
Hana Pharm Co Ltd
Gross Profit Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
H
|
Hana Pharm Co Ltd
KRX:293480
|
Gross Profit
₩141.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Yuhan Corp
KRX:000100
|
Gross Profit
₩689.4B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
8%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Gross Profit
₩504.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Gross Profit
₩817B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Gross Profit
₩99.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
|
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Gross Profit
₩114.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
10%
|
|
Hana Pharm Co Ltd
Glance View
Hana Pharm Co., Ltd. engages in the research, development, and manufacture of pharmaceutical products. The company is headquartered in Hwaseong, Gyeonggi-Do and currently employs 657 full-time employees. The company went IPO on 2018-10-02. The company’s main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The firm also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs.
See Also
What is Hana Pharm Co Ltd's Gross Profit?
Gross Profit
141.3B
KRW
Based on the financial report for Dec 31, 2024, Hana Pharm Co Ltd's Gross Profit amounts to 141.3B KRW.
What is Hana Pharm Co Ltd's Gross Profit growth rate?
Gross Profit CAGR 5Y
5%
Over the last year, the Gross Profit growth was 1%. The average annual Gross Profit growth rates for Hana Pharm Co Ltd have been 3% over the past three years , 5% over the past five years .
You don't have any saved screeners yet